Regulatory Compliance

DCGI & CDSCO Quality Compliance: What Pharmaceutical Distributors Must Verify

26 Oct 2026 • 7 min read • Riomedica Procurement Editorial

Operating a legal pharmaceutical distribution business in India requires strict adherence to central (CDSCO/DCGI) and state drug regulatory authorities.

1. DCGI Drug Approval Verification

Distributors must verify that all fixed-dose combinations (FDCs) in their product portfolio have approved rationales listed on the official DCGI registry, avoiding banned or unapproved formulations.

2. Schedule M & WHO-GMP Good Manufacturing Practices

Schedule M of the Drugs and Cosmetics Act governs cleanroom standards, HVAC air changes, validation protocols, and analytical quality control across pharmaceutical manufacturing units.

3. Good Distribution Practices (GDP) & Record Keeping

Maintaining batch trace registers, temperature-controlled warehousing, and proper tax invoices protects distributors during state drug inspector audits.

Partner with Riomedica Healthcare Pvt. Ltd.

Winner of the Indian Icon Award 2026. Certified WHO-GMP & ISO 9001:2015 pharmaceutical manufacturer offering 715+ formulations with guaranteed quality, prompt dispatch, and dedicated institutional procurement support across India.

Browse 715+ Formulations WhatsApp Enquiry Desk

Frequently Asked Questions

What is the function of DCGI in India?
The Drug Controller General of India sets national standards for drug manufacturing, approves new formulations, and regulates clinical trials.
Why are Certificates of Analysis (COAs) required for every batch?
The COA verifies batch chemical assay, dissolution, and sterility compliance against Indian Pharmacopoeia standards.
B2B Procurement Desk • Pan-India Supply

Enquire for Hospital & Institutional Medicine Supply

Need quotations, bulk rate contracts, or product availability? Complete our quick enquiry form below.

100% Secure & Confidential Fast Quotation TAT